Details

Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 11, 2026 · edition #6
Timestamp: 2026-04-11T14:13:51.064Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-requirements-conducting-clinical-research-psilocybin.html
Replay URL: https://replay.healtharchive.ca/job-6/20260411141351/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-requirements-conducting-clinical-research-psilocybin.html#ha_snapshot=371383
ID: 371383
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots